SEARCH

SEARCH BY CITATION

References

  • 1
    Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 4105.
  • 2
    Vogelsang H, Fereneci P, Woloszczuk FW, Resch H, Frotz HS, Gangl A. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 1989; 34: 10949.
  • 3
    Pigot F, Roux C, Chaussade S, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992; 37: 1396403.
  • 4
    Roux C, Abitbol V, Chaussade S, et al. Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporosis Int 1995; 5: 15660.
  • 5
    Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 41722.
  • 6
    Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995; 10: 2506.
  • 7
    Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 1996; 10: 77786.
  • 8
    Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995; 37: 716.
  • 9
    Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997; 40: 3139.
  • 10
    Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40: 22833.
  • 11
    Boot AM, Bouquet J, Krenning EP, De Muinck Keizer-Schrama SMPF. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 1998; 42: 18894.
  • 12
    Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998; 114: 90211.
  • 13
    Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107: 10319.
  • 14
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 2000; 95: 699704.
    Direct Link:
  • 15
    Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000; 46: 17681.
  • 16
    Bernstein CN, Blanchard JF, Leslie W, Wajde A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease—a population-based cohort study. Ann Intern Med 2000; 133: 7959.
  • 17
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998; 93: 148390.
    Direct Link:
  • 18
    Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988; 29: 13326.
  • 19
    Motley RJ, Clements D, Evans WD, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993; 23: 95104.
  • 20
    Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJM. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 2000; 119: 12038.
  • 21
    Andreassen H, Rungby J, Dahlerup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997; 32: 124755.
  • 22
    Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 1989; 298: 826.
  • 23
    Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1: 514.
  • 24
    Drossman DA, Richter JE, Talley NJ, eds. The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment, 1st edn. McLean, VA: Degnon Associates, 1994.
  • 25
    Looker AC, Wahner HW, Dunn WL. Proximal femur bone mineral levels of US adults. Osteoporosis Int 1995; 5: 389409.
  • 26
    World Health Organization. Assessment of fracture risk and its application to screening for post-menopausal osteoporosis. Technical Report Series 843. Geneva: WHO, 1994.
  • 27
    Qasim A, Seery J, Morain CAO. Osteoporosis in newly diagnosed inflammatory bowel disease. Gastroenterology 2001; 121: 5045.
  • 28
    Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982; 83: 12528.
  • 29
    Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985; 26: 1197203.
  • 30
    Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998; 12: 699705.
  • 31
    Dawson-Hughes B, Harris SS, Dallal GE. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997; 65: 6771.
  • 32
    Compston JE, Creamer B. Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut 1977; 18: 1715.
  • 33
    Chapuy M-C, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 1997; 7: 43943.
  • 34
    Heaney RP. Vitamin D: how much do we need, and how much is too much? Osteoporosis Int 2000; 11: 5535.
  • 35
    Scharla SH, Minne HW, Lempert UG, et al. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol 1994; 102: 449.
  • 36
    Compston JE. Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995; 9: 23750.
  • 37
    Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis Int 1993; 3: 23641.
  • 38
    Lin C, Moniz C, Chambers TJ, Chow JWM. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 1996; 111: 126371.
  • 39
    Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut 2000; 46(Suppl. 1): 18.
  • 40
    Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995; 7: 60914.
  • 41
    Abitbol V, Mary JY, Roux C, et al. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 2002; 16: 91927.
  • 42
    Nemetz A, Toth M, Garcia-Gonzalez MA, et al. Allelic variation at the interleukin 1B gene is associated with decreased bone mass in patients with inflammatory bowel diseases. Gut 2001; 49: 6449.